Physical Evidence of the Coupling of Solubilized 5-HT1A Binding Sites with G Regulatory Proteins
Overview
Pharmacology
Authors
Affiliations
Previous investigations (El Mestikawy et al., J Neurochem 51: 1031-1040, 1988) have shown that 5-HT1A binding sites (R[5-HT1A]) solubilized by CHAPS from rat hippocampal membranes can be modulated by guanine nucleotides, as expected from their solubilization together with associated G regulatory proteins (G). Studies of the hydrodynamic properties of solubilized R[5-HT1A] have been presently carried out in order to assess in a more direct way the presence of R[5-HT1A]-G complexes in the soluble extract. Under control conditions, the sedimentation of a CHAPS extract from hippocampal membranes through a 5-30% sucrose gradient (200,000 g, 17 hr, 4 degrees) gave two maxima of [3H]8-OH-DPAT binding activity corresponding to sedimentation coefficients of 8.0 S and 10.0 S, respectively. Running the gradient in the presence of 1 microM GTP revealed a significant reduction of the 10.0 S peak, as expected from the loss of material (probably a G protein) normally associated with R[5-HT1A]. Conversely, attempts to prevent the dissociation of R[5-HT1A]-G by treatment of CHAPS soluble hippocampal extracts with the cross-linking reagent disuccinimidyl suberate (0.1 mM) resulted in a significant increase (+70%) in [3H]8-OH-DPAT binding activity associated with the appearance of a new sedimenting material with a higher coefficient (16.5 S). Furthermore, [3H]8-OH-DPAT binding became almost completely insensitive to guanine nucleotides as expected from the irreversible coupling by disuccinimidyl suberate of R[5-HT1A] with G protein(s). WGA-agarose chromatography of CHAPS soluble hippocampal extract supplemented with GTP allowed the physical separation of R[5-HT1A] from the bulk of G proteins, and a concomitant decrease of [3H]8-OH-DPAT high affinity binding capacity. Partial recovery of the latter could be achieved by reconstituting R[5-HT1A]-G complexes upon the addition of a mixture of pure bovine Gi + Go to G-deprived soluble extracts. Finally in vivo treatment with Pertussis toxin (5 micrograms intracerebroventricularly, 48 hr before killing) resulted in a significant reduction of the specific binding of [3H]8-OH-DPAT (-36%) to hippocampal membranes and corresponding CHAPS soluble extracts, and a marked decrease in the inhibitory effect of GppNHp. Accordingly the G protein associated with R[5-HT1A] belongs probably to the Gi or Go families.
Sarkar P, Bhat A, Chattopadhyay A J Membr Biol. 2022; 255(6):739-746.
PMID: 35986776 DOI: 10.1007/s00232-022-00262-w.
Razakarivony O, Newman-Tancredi A, Zimmer L Transl Psychiatry. 2021; 11(1):22.
PMID: 33414418 PMC: 7791062. DOI: 10.1038/s41398-020-01119-3.
Pharmacological agonists for more-targeted CNS radio-pharmaceuticals.
Zimmer L Oncotarget. 2016; 7(49):80111-80112.
PMID: 27861159 PMC: 5348308. DOI: 10.18632/oncotarget.13418.
Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.
Saunders C, Siuta M, Robertson S, Davis A, Sauer J, Matthies H Neurochem Int. 2013; 73:113-121.
PMID: 24090638 PMC: 4073299. DOI: 10.1016/j.neuint.2013.09.015.
[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A Eur J Nucl Med Mol Imaging. 2009; 37(3):594-605.
PMID: 19789870 DOI: 10.1007/s00259-009-1274-y.